{
    "organizations": [],
    "uuid": "188c8cfbe20ef96d7cd31cc332e55136bdfcce66",
    "author": "",
    "url": "https://www.reuters.com/article/brief-tesaro-summarizes-tsr-042-clinical/brief-tesaro-summarizes-tsr-042-clinical-data-presented-at-aacr-idUSFWN1RT0N9",
    "ord_in_thread": 0,
    "title": "BRIEF-Tesaro Summarizes TSR-042 Clinical Data Presented At AACR",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16, 2018 / 1:06 PM / Updated 9 minutes ago BRIEF-Tesaro Summarizes TSR-042 Clinical Data Presented At AACR Reuters Staff \nApril 16 (Reuters) - TESARO Inc: \n* TESARO SUMMARIZES TSR-042 CLINICAL DATA PRESENTED AT AACR \n* TESARO INC - EXPECT TO COMPLETE ENROLLMENT IN MSI-H ENDOMETRIAL COHORT OF GARNET TRIAL BY END OF YEAR Source text for Eikon: Further company coverage:",
    "published": "2018-04-16T16:05:00.000+03:00",
    "crawled": "2018-04-16T16:22:57.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "pm",
        "updated",
        "minute",
        "ago",
        "summarizes",
        "clinical",
        "data",
        "presented",
        "aacr",
        "reuters",
        "staff",
        "april",
        "reuters",
        "tesaro",
        "inc",
        "tesaro",
        "summarizes",
        "clinical",
        "data",
        "presented",
        "aacr",
        "tesaro",
        "inc",
        "expect",
        "complete",
        "enrollment",
        "endometrial",
        "cohort",
        "garnet",
        "trial",
        "end",
        "year",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}